Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Telaprevir

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Recent Success in HCV Treatment Brings Relief to Patients
    Recent Success in HCV Treatment Brings Relief to Patients

    07 Nov 2016

    // DRUG DEVELOPMENT

    http://www.drug-dev.com/Main/Back-Issues/HCV-MARKET-Recent-Success-in-HCV-Treatment-Brings-1213.aspx

    DRUG DEVELOPMENT
    07 Nov 2016
    Share Share
    Hovione to build US plant for Vertex's cystic fibrosis drugs
    Hovione to build US plant for Vertex's cystic fibrosis drugs

    10 Mar 2016

    // Gareth MacDonald+ IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/Hovione-to-build-US-plant-for-Vertex-s-cystic-fibrosis-drugs

    Gareth MacDonald+ IN PHARMATECHNOLOGIST
    10 Mar 2016
    Share Share
    Advera: Harvoni bests Sovaldi, Viekira Pak in hep C drug safety
    Advera: Harvoni bests Sovaldi, Viekira Pak in hep C drug safety

    10 Dec 2015

    // Emily Wasserman FIERCE PHARMA

    http://www.fiercepharma.com/story/advera-harvoni-bests-sovaldi-viekira-pak-hep-c-drug-safety/2015-12-09

    Emily Wasserman FIERCE PHARMA
    10 Dec 2015
    Share Share
    Once a Takeover Candidate, Vertex Is Now Looking for Deals
    Once a Takeover Candidate, Vertex Is Now Looking for Deals

    04 Nov 2015

    // Doni Bloomfield BLOOMBERG

    http://www.bloomberg.com/news/articles/2015-11-04/once-a-takeover-candidate-vertex-is-now-looking-to-acquire?

    Doni Bloomfield BLOOMBERG
    04 Nov 2015
    Share Share
    Mid-cap biotech beats most of the big dogs with 21.9% revenue growth
    Mid-cap biotech beats most of the big dogs with 21.9% revenue growth

    08 Apr 2015

    // Carly Helfand FIERCE PHARMA

    http://www.fiercepharma.com/story/mid-cap-biotech-beats-most-big-dogs-219-revenue-growth/2015-04-08

    Carly Helfand FIERCE PHARMA
    08 Apr 2015
    Share Share
    Another One Bites The Dust: Merck Cans Hep C Fighter Victrelis as New Meds Take Flight
    Another One Bites The Dust: Merck Cans Hep C Fighter Victrelis as New Meds Take Flight

    22 Jan 2015

    // Tracy Staton FIERCE PHARMA

    http://www.fiercepharma.com/story/another-one-bites-dust-merck-cans-hep-c-fighter-victrelis-new-meds-take-fli/2015-01-21

    Tracy Staton FIERCE PHARMA
    22 Jan 2015
    Share Share